GlassScriptPhysician profile
Tim Nguyen
NPI 1033721923
$747.34
in general payments reported to CMS, 2019-2025
11 companies · $275 in 2025
The $275 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $117 · 2023: $34.44 · 2024: $321 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $630.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $211.08 | 2024 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Novo Nordisk INC | $121.81 | 2025 | Wegovy |
| Alexion Pharmaceuticals, INC. | $116.55 | 2022 | |
| Glaukos Corporation | $71.14 | 2025 | Kxl System (Not Refurbished) |
| E.R. Squibb & Sons, L.L.C. | $62.32 | 2025 | Breyanzi |
| Daiichi Sankyo INC. | $40.41 | 2024 | Vanflyta |
| Abbvie INC. | $33.24 | 2023-2025 | |
| Sobi, INC | $32.16 | 2024 | |
| Bioventus LLC | $21.24 | 2023 | Durolane |
| Merck Sharp & Dohme LLC | $20.47 | 2024 | Keytruda, Lynparza |
| Mirati Therapeutics, INC. | $16.92 | 2024 | Krazati |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tim Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.